1057464

Janssen Biotech Inc. — FEI 3006473233

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 22, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Horsham, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)